MUFG Securities Americas’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
17,342
+1,285
+8% +$108K 0.08% 225
2026
Q1
$1.29M Buy
16,057
+424
+3% +$35K 0.08% 220
2025
Q4
$1.33M Sell
15,633
-199
-1% -$16.3K 0.08% 209
2025
Q3
$1.23M Buy
15,832
+2,832
+22% +$221K 0.08% 220
2025
Q2
$1.02M Buy
13,000
+2,560
+25% +$191K 0.09% 207
2025
Q1
$757K Buy
10,440
+1,734
+20% +$124K 0.09% 215
2024
Q4
$645K Buy
+8,706
New +$609K 0.08% 214

Other funds holding EW

MUFG Securities Americas's EW Position: Q2 2026 in Review

MUFG Securities Americas increased its Edwards Lifesciences (EW) stake by 8% in Q2 2026, buying an estimated $108K and bringing the position to 17,342 shares worth $1.57M. The position accounts for 0.08% of the portfolio, ranked #225.

MUFG Securities Americas first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MUFG Securities Americas held 17,342 shares of Edwards Lifesciences worth $1.57M as of Q2 2026.
  • MUFG Securities Americas bought 1,285 Edwards Lifesciences shares in Q2 2026, an estimated $108K.
  • Edwards Lifesciences made up 0.08% of MUFG Securities Americas's portfolio in Q2 2026, its #225 holding.
  • MUFG Securities Americas first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.